Commentary on a study on the identification of patients at risk for mortality early in the course of acute pancreatitis, published December 2008 in Gut.
In this Medscape Oncology Minute, Dr. Howard Hochster reports on the first definitive trial to show a benefit of combination therapy in patients with unresectable or recurrent biliary cancers. Medscape Hematology-Oncology
The nonsteroidal anti-inflammatory drug (NSAID) sulindac and its metabolites induce carcinogen-metabolizing enzymes in human colon cancer cells, according to a report in the March 1st International Journal of Cancer. Reuters Health Information
A3309, a bile acid transporter inhibitor helps alleviate chronic idiopathic constipation (CIC), researchers report in a May 24th online paper in the American Journal of Gastroenterology. br / iReuters Health Information/i
Colon cancer before the age of 50 might be an indication that the patient has Lynch syndrome; screening can identify these individuals. br / iMedscape Medical News/i
